~~<i id='6C40A56A63'><strike id='6C40A56A63'><tt id='6C40A56A63'><pre id='6C40A56A63'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：leisure time 2025-09-10 08:44:00 - browse：88785

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： NEJM study measures Covid brain fog, impact on IQ

Wikipedia

explore

entertainment

Wikipedia

hotspot

AhealthcareworkeradministersaCovid-19boostershot.JensSchlueter/GettyImagesAnexpertpaneladvisingtheCe

WSS

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Color Health wants to make cancer screenings convenient

BD to buy Edwards patient monitoring unit for $4.2 billion

Childhood vaccination ad campaign launches in the U.K.

Finland to offer bird flu vaccine to select groups of people, a possible global first

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

focus

focus

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare isn't yet testing food as medicine

As demand for Covid shots wanes, Moderna seeks its next success

Elisabeth Bik tackles the widespread issue of research misconduct

Medicare details structure of new drug price negotiation program

Senators tussle over abortion against the backdrop of a presidential campaign

Alkermes shareholders re

Readout Newsletter: Beam, Prozac, "TechBio" and more

ChatGPT in medicine: STAT answers readers' burning questions

Illumina board agrees to spin off Grail, as divestment plans proceed

explore

Study fuels hope CAR

Structure Therapeutics oral GLP

Illumina board agrees to spin off Grail, as divestment plans proceed

Stopping antidepressants leads to symptoms for 1 in 6 patients

Cholera vaccine supplies dangerously low, outbreaks surging

Structure Therapeutics oral GLP

explore

entertainment

Wikipedia

hotspot